Not applicableLooking for participantsNCT03504007What this trial is testingRegistry of Patients Prescribed AnticoagulationWho this might be right forAcute Deep Vein ThrombosisAcute Pulmonary Embolism Mayo Clinic 10,000
Early research (Phase 1)Study completedNCT06945276What this trial is testingPhase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy VolunteersWho this might be right forCOVID-19 National Institute of Allergy and Infectious Diseases (NIAID) 51
Early research (Phase 1)Study completedNCT05492318What this trial is testingPerpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp ActivityWho this might be right forDrug-Drug InteractionHeathy Volunteer Italfarmaco 26
Post-approval studies (Phase 4)Study completedNCT01493557What this trial is testingA Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial FibrillationWho this might be right forAtrial Fibrillation Boehringer Ingelheim 1,067
Not applicableUnknownNCT06387407What this trial is testingPopulation Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of DabigatranWho this might be right forCombined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters The Affiliated Hospital Of Guizhou Medical University 30
Not applicableStudy completedNCT03258645What this trial is testingThis Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a StrokeWho this might be right forAtrial Fibrillation Boehringer Ingelheim 1,489
Not applicableStudy completedNCT02684981What this trial is testingPatient Convenience Study (RE-SONANCE)Who this might be right forAtrial FibrillationStroke Boehringer Ingelheim 9,472
Early research (Phase 1)Study completedNCT02171572What this trial is testingSingle and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese SubjectsWho this might be right forHealthy Boehringer Ingelheim 28
Not applicableStudy completedNCT02904499What this trial is testingUse of Public Health Surveillance Models in the French National Health System DatabaseWho this might be right forAtrial FibrillationAnticoagulantsPharmacoepidemiology Centre Hospitalier Universitaire de la Réunion 814,446
Not applicableWithdrawnNCT03537521What this trial is testingReversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New AntidotsWho this might be right forSevere BleedingUrgent Surgery Cardioangiologisches Centrum Bethanien
Post-approval studies (Phase 4)Study completedNCT01339819What this trial is testingImpact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial FibrillationWho this might be right forAtrial Fibrillation Deutsches Herzzentrum Muenchen 70
Not applicableStudy completedNCT02849509What this trial is testingPatient Convenience Study- NIS RELATEWho this might be right forAtrial Fibrillation Boehringer Ingelheim 1,313
Large-scale testing (Phase 3)Study completedNCT00657150What this trial is testingDabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip ArthroplastyWho this might be right forVenous Thromboembolism Boehringer Ingelheim 2,055
Post-approval studies (Phase 4)UnknownNCT04688723What this trial is testingDual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCIWho this might be right forCoronary Artery DiseaseMyocardial IschemiaMyocardial Infarction+1 more Zuyderland Medisch Centrum 1,000
Not applicableEnded earlyNCT05966740What this trial is testingA Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotWho this might be right forVenous Thromboembolism Boehringer Ingelheim 5
Post-approval studies (Phase 4)Active Not RecruitingNCT03129490What this trial is testingThe Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial FibrillationWho this might be right forAtrial FibrillationAtrial Flutter Herlev and Gentofte Hospital 11,000
Early research (Phase 1)Study completedNCT01590823What this trial is testingAn Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis PatientsWho this might be right forBlood Coagulation Disorders Nova Scotia Health Authority 10
Early research (Phase 1)WithdrawnNCT03752294What this trial is testingA Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.Who this might be right forMild Cognitive ImpairmentMild Alzheimer's Disease University of Rhode Island
Post-approval studies (Phase 4)Study completedNCT01468155What this trial is testingDAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial FibrillationWho this might be right forAtrial Fibrillation London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50
Not applicableStudy completedNCT03280368What this trial is testingAdherence and Coagulation Assays in Dabigatran-treated Patients With Atrial FibrillationWho this might be right forAtrial FibrillationMedication AdherenceBlood Coagulation Tests+10 more Hospitalsenheden Vest 430